South Korea · Delayed Price · Currency is KRW METACARE CO. Statistics
Total Valuation
METACARE CO. has a market cap or net worth of KRW 23.34 billion. The enterprise value is 74.76 billion.
| Market Cap | 23.34B |
| Enterprise Value | 74.76B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
METACARE CO. has 17.18 million shares outstanding. The number of shares has increased by 401.06% in one year.
| Current Share Class | 17.18M |
| Shares Outstanding | 17.18M |
| Shares Change (YoY) | +401.06% |
| Shares Change (QoQ) | +1,114.28% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 9.92M |
Valuation Ratios
The trailing PE ratio is 98.55.
| PE Ratio | 98.55 |
| Forward PE | n/a |
| PS Ratio | 0.63 |
| PB Ratio | 0.19 |
| P/TBV Ratio | 0.23 |
| P/FCF Ratio | 5.66 |
| P/OCF Ratio | 4.75 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.75, with an EV/FCF ratio of 18.13.
| EV / Earnings | 80.94 |
| EV / Sales | 2.02 |
| EV / EBITDA | 15.75 |
| EV / EBIT | 54.64 |
| EV / FCF | 18.13 |
Financial Position
The company has a current ratio of 0.32, with a Debt / Equity ratio of 0.43.
| Current Ratio | 0.32 |
| Quick Ratio | 0.23 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 11.04 |
| Debt / FCF | 12.71 |
| Interest Coverage | 0.52 |
Financial Efficiency
Return on equity (ROE) is 0.38% and return on invested capital (ROIC) is 0.78%.
| Return on Equity (ROE) | 0.38% |
| Return on Assets (ROA) | 0.47% |
| Return on Invested Capital (ROIC) | 0.78% |
| Return on Capital Employed (ROCE) | 1.11% |
| Weighted Average Cost of Capital (WACC) | 5.03% |
| Revenue Per Employee | 1.19B |
| Profits Per Employee | 29.79M |
| Employee Count | 31 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 24.69 |
Taxes
| Income Tax | -31.45M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.00% in the last 52 weeks. The beta is 0.57, so METACARE CO.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -60.00% |
| 50-Day Moving Average | 2,083.98 |
| 200-Day Moving Average | 2,878.20 |
| Relative Strength Index (RSI) | 26.49 |
| Average Volume (20 Days) | 105,466 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, METACARE CO. had revenue of KRW 36.95 billion and earned 923.61 million in profits. Earnings per share was 13.79.
| Revenue | 36.95B |
| Gross Profit | 10.71B |
| Operating Income | 1.37B |
| Pretax Income | 423.89M |
| Net Income | 923.61M |
| EBITDA | 4.75B |
| EBIT | 1.37B |
| Earnings Per Share (EPS) | 13.79 |
Balance Sheet
The company has 2.78 billion in cash and 52.39 billion in debt, with a net cash position of -49.61 billion or -2,888.22 per share.
| Cash & Cash Equivalents | 2.78B |
| Total Debt | 52.39B |
| Net Cash | -49.61B |
| Net Cash Per Share | -2,888.22 |
| Equity (Book Value) | 121.63B |
| Book Value Per Share | 574.38 |
| Working Capital | -44.31B |
Cash Flow
In the last 12 months, operating cash flow was 4.92 billion and capital expenditures -796.03 million, giving a free cash flow of 4.12 billion.
| Operating Cash Flow | 4.92B |
| Capital Expenditures | -796.03M |
| Depreciation & Amortization | 3.38B |
| Net Borrowing | 2.73B |
| Free Cash Flow | 4.12B |
| FCF Per Share | 240.01 |
Margins
Gross margin is 28.98%, with operating and profit margins of 3.70% and 2.50%.
| Gross Margin | 28.98% |
| Operating Margin | 3.70% |
| Pretax Margin | 1.15% |
| Profit Margin | 2.50% |
| EBITDA Margin | 12.84% |
| EBIT Margin | 3.70% |
| FCF Margin | 11.16% |
Dividends & Yields
METACARE CO. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -401.06% |
| Shareholder Yield | -401.06% |
| Earnings Yield | 3.96% |
| FCF Yield | 17.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 24, 2026. It was a reverse split with a ratio of 0.1.
| Last Split Date | Apr 24, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
METACARE CO. has an Altman Z-Score of -0.11 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.11 |
| Piotroski F-Score | 5 |